POS0653 IMPACT OF UPADACITINIB OR ADALIMUMAB AS INITIAL THERAPY ON THE ACHIEVEMENT OF 48-WEEK TREATMENT GOALS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: POST HOC ANALYSIS OF A PHASE 3 STUDY
Mysler, E., Tanaka, Y., Kavanaugh, A., Aletaha, D., Taylor, P. C., Song, I. H., Shaw, T., Song, Y., Demasi, R., Ali, M., Fleischmann, R.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
POS0087 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 3 YEARS FROM THE SELECT-COMPARE STUDY
Fleischmann, R., Mysler, E., Bessette, L., Peterfy, C., Durez, P., Tanaka, Y., Swierkot, J., Khan, N., Bu, X., LI, Y., Song, I. H.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
POS0652 SEX DIFFERENCES IN THE EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS: A POST HOC ANALYSIS OF PHASE 3 AND LONG-TERM EXTENSION TRIALS
Jones, H. N., Strand, V., Schulze-Koops, H., Mysler, E., Kinch, C., Gruben, D. C., Germino, R., Connell, C. A., Eder, L.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
FRI0034 Efficacy of etanercept by body mass index in women and men with rheumatoid arthritis: a post hoc analysis of three randomised trials
Alten, R., Mysler, E., Wajdula, A., Jones, H.E., Pedersen, R., Marshall, L.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
Schnitzer, Thomas J, Burmester, Gerd R, Mysler, Eduardo, Hochberg, Marc C, Doherty, Michael, Ehrsam, Elena, Gitton, Xavier, Krammer, Gerhard, Mellein, Bernhard, Matchaba, Patrice, Gimona, Alberto, Hawkey, Christopher J
Published in The Lancet (British edition) (21.08.2004)
Published in The Lancet (British edition) (21.08.2004)
Get full text
Journal Article
FRI0140 IMPACT OF BASELINE DEMOGRAPHICS AND DISEASE ACTIVITY ON OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB
Weinblatt, M., Mysler, E., Ostor, A., Broadwell, A., Jeka, S., Dunlap, K., Suboticki, J., Enejosa, J., Hendrickson, B., Zhong, S., Cherny, K., Wright, G.
Published in Annals of the rheumatic diseases (01.06.2020)
Published in Annals of the rheumatic diseases (01.06.2020)
Get full text
Journal Article
SAT0256 Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: patient-reported outcomes from a phase 3b/4 randomised trial
Strand, V., Mysler, E., Moots, R.J., Wallenstein, G., DeMasi, R., Gruben, D., Soma, K., Iikuni, N., Fleischmann, R.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
Farkouh, Michael E, Kirshner, Howard, Harrington, Robert A, Ruland, Sean, Verheugt, Freek WA, Schnitzer, Thomas J, Burmester, Gerd R, Mysler, Eduardo, Hochberg, Marc C, Doherty, Michael, Ehrsam, Elena, Gitton, Xavier, Krammer, Gerhard, Mellein, Bernhard, Gimona, Alberto, Matchaba, Patrice, Hawkey, Christopher J, Chesebro, James H
Published in The Lancet (British edition) (21.08.2004)
Published in The Lancet (British edition) (21.08.2004)
Get full text
Journal Article
PANLAR consensus statement on biosimilars
Kowalski, S. C., Benavides, J. A., Roa, P. A. B., Galarza-Maldonado, C., Caballero-Uribe, C. V., Soriano, E. R., Pineda, C., Azevedo, V. F., Avila-Pedretti, G., Babini, A. M., Cachafeiro-Vilar, A., Cifuentes-Alvarado, M., Cohen, S. B., Díaz, P. E., Soto, L. Diaz, Encalada, C., Garro, B., Sariego, I. A. G., Guibert-Toledano, M., Rodriguez, V. J. K., Lopez, M. E. L., Ortega, A. P., Russell, A. S., Santos-Moreno, P., Terán, I. S., Vargas, A., Vásquez, G., Xavier, R. M., Firedman, D. X. Xibillé, Mysler, E., Kay, J.
Published in Clinical rheumatology (01.05.2019)
Published in Clinical rheumatology (01.05.2019)
Get full text
Journal Article
FRI0227 Five-Year Safety and Efficacy of Subcutaneous Abatacept in Patients with Moderate To Severely Active RA and An Inadequate Response To MTX: Long-Term Extension of The Phase III, Double-Blind, Randomized Acquire Study
Genovese, M.C., Pacheco Tena, C., Covarrubias, A., Leon, G., Mysler, E., Keiserman, M., Valente, R., Nash, P., Simon-Campos, J.A., Box, J., Legerton, C.W., Nasonov, E., Durez, P., Elegbe, A., Wong, R., Li, X., Banerjee, S., Alten, R.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
SAT0244 A Phase Iib Study of the Efficacy and Safety of Subcutaneous Clazakizumab (ANTI-IL-6 Monoclonal Antibody) with or without Methotrexate in Adults with Moderate-To-Severe Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Weinblatt, M., Mease, P., Mysler, E., Takeuchi, T., Drescher, E., Berman, A., Zilberstein, M., Xing, J., Emery, P.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article
SAT0189 Rapid Onset of Clinical Benefit in Patients with RA Treated with Mavrilimumab, A Fully Human Monoclonal Antibody Targeting GM–CSFR-ALPHA: Subanalysis of the Phase IIB Earth Explorer 1 Study
McInnes, I.B., Burmester, G.R., Kremer, J.M., Miranda, P., Korkosz, M., Vencovsky, J., Rubbert-Roth, A., Mysler, E., Close, D., Sleeman, M., Godwood, A., Albulescu, M., Weinblatt, M.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
OP0034 Efficacy and Safety of Mavrilimumab, A Fully Human Gm–CSFR-Alpha Monoclonal Antibody in Patients with Rheumatoid Arthritis: Primary Results from the Earth Explorer 1 Study
Burmester, G.R., McInnes, I.B., Kremer, J.M., Miranda, P., Korkosz, M., Vencovsky, J., Rubbert-Roth, A., Mysler, E., Sleeman, M.A., Godwood, A., Albulescu, M., Close, D., Weinblatt, M.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
Correction to: PANLAR consensus statement on biosimilars
Kowalski, S. C., Benavides, J. A., Beltrán, P. A., Galarza-Maldonado, C., Caballero-Uribe, C. V., Soriano, E. R., Pineda, C., Azevedo, V. F., Avila-Pedretti, G., Babini, A. M., Cachafeiro-Vilar, A., Cifuentes-Alvarado, M., Cohen, S. B., Díaz, P. E., Diaz-Coto, J. F., Encalada, C., Garro, B., Sariego, I. A. G., Guibert-Toledano, M., Rodriguez, V. J. K., Lopez, M. E. L., Ortega, A. P., Russell, A. S., Santos-Moreno, P., Terán, I. S., Vargas, A., Vásquez, G., Xavier, R. M., Firedman, D. X. Xibillé, Mysler, E., Kay, J.
Published in Clinical rheumatology (01.07.2019)
Published in Clinical rheumatology (01.07.2019)
Get full text
Journal Article
FRI0316 The Efficacy and Safety of Subcutaneous Tocilizumab versus Intravenous Tocilizumab in Combination with Traditional DMARDS in Patients with RA at Week 97 (SUMMACTA)
Burmester, G., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M.J., Roane, G., Ludivico, C., Mysler, E., Bennett, M.J., Rowell, L., Bao, M.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article
Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout
Willburger, R. E., Mysler, E., Derbot, J., Jung, T., Thurston, H., Kreiss, A., Litschig, S., Krammer, G., Tate, G. A.
Published in Rheumatology (Oxford, England) (01.07.2007)
Published in Rheumatology (Oxford, England) (01.07.2007)
Get full text
Journal Article
FRI0123 Biologic monotherapy (BMT) as a treatment pattern in ra patients in a developing country
Mysler, E., Alvarellos, A., Borgia, A., Eimon, A., García Salinas, R., Najún Dubos, L., Re, L., Siri, D., Solé, J. P., Sommerfleck, F., Velasco Zamora, J., Wiederhold, C.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
THU0246 Subcutaneous Abatacept: Long-Term Data From the Acquire Trial
Alten, R., Pacheco-Tena, C., Covarrubias, A., Leon, G., Mysler, E., Keiserman, M., Valente, R., Nash, P., Simon-Campos, J., Box, J., Legerton, C., Nasonov, E., Durez, P., Delaet, I., Genovese, M.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra
Burmester, G. R., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M. J., Roane, G., Ludivico, C., Mysler, E., Rowell, L., Vranic, I.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article